Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07035925 · ClinicalTrials.gov registry record · NA
Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas
A NA study of Fistula-in-ano, sponsored by ECM Therapeutics.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT07035925: Recruiting NA study of Fistula-in-ano, sponsored by ECM Therapeutics.
NCT07035925 is a NA study of Fistula-in-ano that is actively recruiting participants, run by ECM Therapeutics. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07035925, a NA study of Fistula-in-ano, is actively recruiting participants, sponsored by ECM Therapeutics.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
Safety and Efficacy of ECMT-100 for the Treatment of Anorectal Fistulas
Primary Outcome
Number of Adverse Events
Conditions Studied
Interventions
- DEVICE ECMT-100
Study Locations (2)
New Hampshire
- Dartmouth Hitchcock Medical Center - Lebanon
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-11-24 |
| Est. Completion | 2028-04-24 |
| Phase | NA |
What NCT07035925 shows while recruiting
NCT07035925 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Fistula-in-ano appearing as the primary indexed condition, and to 1 intervention - of which ECMT-100 is the first listed.
NCT07035925 reports a single indexed study location in New Hampshire, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07035925 about?
NCT07035925 is a clinical study titled "Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas". Safety and Efficacy of ECMT-100 for the Treatment of Anorectal Fistulas
What is the current status of trial NCT07035925?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-11-24. Estimated completion is 2028-04-24.
What conditions does trial NCT07035925 study?
This clinical trial studies the following conditions: Fistula-in-ano.
What interventions are being tested in trial NCT07035925?
The interventions under investigation include: ECMT-100 (DEVICE).
Who is sponsoring clinical trial NCT07035925?
This trial is sponsored by ECM Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07035925 being conducted?
This trial has 2 study locations across New Hampshire, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fistula-in-ano
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07035925's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI